MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • BioDelivery Sciences International, Inc. (BDSI) Recruits David Acheson To The Position Of Vice President Of Sales And Managed Markets 0 comments
    Dec 4, 2013 2:43 PM | about stocks: BDSI

    BioDelivery Sciences International announced the hiring of David Acheson as its new Vice President of Sales and Managed Markets.

    Acheson has over 18 years of pharmaceutical and biotech sales and commercial experience and will oversee the sales and managed markets support behind the anticipated launch of BUNAVAIL, currently set to take place in 2014. He will also oversee both current and upcoming commercial partnerships.

    Acheson's most recently held responsibility was implementing the strategy and full build out and deployment of the sales organization for Pacira Pharmaceuticals Inc., an emerging specialty pharmaceutical company focused specifically on the clinical and commercial development of products in the post-surgical pain market. It was there that he played an instrumental role in the successful introduction of Exparel in 2012. In addition, Acheson's experience includes a position with CSL Behring as the National Director of Sales, Immunology and Pulmonary for two specialty teams focused in rare and orphan diseases.

    "We are extremely fortunate to have someone with David's talent and energy join our management team during this exciting and evolutionary phase of our company as we progress from a research and development focused company to a broader commercial entity," stated President and Chief Executive Officer of BDSI, Dr. Mark A. Sirgo,. "The timing of David's hiring is significant as we finalize our commercial plans for BUNAVAIL over the next several months. In parallel with our partnering discussions, we are making the appropriate plans to also launch BUNAVAIL. Regardless of which pathway we ultimately determine provides the best opportunity for the long term success of BUNAVAIL and BDSI's other products, David will oversee the sales and managed markets effort."

    Acheson's pharmaceutical and biotech career began with Roche Pharmaceuticals where he held the position of Sales Representative, Medical Center Representative, and Division Sales Manager. After five years in the hospital and oncology supportive care sector at Roche, Acheson joined MedPointe/Meda Pharmaceuticals where he progressed through multiple areas of responsibility in sales as a District Sales Manager, Regional Sales Director, and National Sales Director in the respiratory business. Also at Meda, Acheson served as the National Sales Director, Pain and Supportive Care Team, and was responsible for building a full pain and oncology supportive care division of the company, deploying a sales team as well as overseeing the operational needs within the company.

    Acheson has experience in a number of complex markets, some of which include pain, palliative care, immunotherapy and orphan disease state products, many of which afforded him a great deal of involvement in the equally complex managed markets arena, developing and executing payer strategies as well as partnerships at the distribution and channel level. Acheson has worked in collaborative partnerships and has substantial expertise in working with contract sales organizations.

    For more information, visit bdsi.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: BDSI
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.